Ovarian cancer isn't silent - learn the early warning signs. Persistent bloating, pelvic pain, urinary symptoms revealed.

Get Instant Summarized Text (Gist) DNM1 is identified as a key non-transcriptional regulator of epithelial-to-mesenchymal transition (EMT) in ovarian cancer, promoting metastasis by facilitating N ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

One woman's story of literal strength illustrates how ovarian cancer symptoms can be missed—and the lighthearted recovery ...

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because current treatments are not effective once the cancer has spread ...

IBI354 has demonstrated promising anti-tumor efficacy and favorable safety profiles across multiple solid tumors. It not only holds potential to deliver a new generation of ADC therapies characterized ...

Overall, these findings establish the DNM1-N-cadherin axis as a critical regulator of EMT-associated ovarian cancer metastasis and suggest its potential as a biomarker for targeted nanodrug therapy.

Jacquie Beltrao issued a huge announcement five years after she was told she had stage four breast cancer. The Sky News ...

Diane Boothby, 65, was diagnosed with ovarian cancer in January 2022 - and has since gone on to host various fundraisers and ...

Verastem Oncology jumps 22% on FDA nod for Avmapki Fakzynja, the first approved KRAS-mutant LGSOC therapy, with strong early data in a pancreatic cancer study.

It’s often diagnosed at a late stage. But with a new blood test, scientists believe that survival rates could soar.